Skip to content

Abnormal Circulating Fetuin A Concentration C5539500

Published: July 22, 2026Updated: August 20, 2026

Fetuin A is a protein made by the liver involved in metabolism and bone health. Abnormal levels may be associated with various conditions and require further evaluation.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Severe chest pain

Intense, crushing chest pain that may radiate to the arms, jaw, or back

Call emergency services immediately if experiencing severe, crushing chest pain or symptoms of a heart attack

!

Loss of consciousness

Sudden fainting or loss of consciousness, which may indicate a serious cardiac or vascular event

Call emergency services immediately if someone loses consciousness, even if they regain consciousness

Fatigue

(constitutional)

Persistent tiredness and lack of energy that does not improve with rest

Frequency: 60-70% of patients

Reduced exercise tolerance

(constitutional)

Decreased ability to perform physical activity due to quick onset of tiredness

Frequency: 50-60% of patients

Abdominal discomfort

(gastrointestinal)

Generalized pain or unease in the abdominal region, often associated with digestive disturbances

Frequency: 40-50% of patients

Decreased appetite

(gastrointestinal)

Reduced desire to eat, potentially leading to unintended weight loss

Frequency: 35-45% of patients

Chest discomfort

(cardiovascular)

Pressure, tightness, or mild pain in the chest area that may come and go

Frequency: 20-30% of patients

Shortness of breath

(respiratory)

Difficulty breathing or feeling breathless, especially during physical exertion

Frequency: 15-25% of patients

Muscle weakness

(neurologic)

Generalized reduced muscle strength and endurance affecting daily activities

Frequency: 15-20% of patients

Leg swelling

(cardiovascular)

Swelling in the lower legs and ankles due to fluid retention

Frequency: 10-20% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive metabolic risk reduction

Multifactorial lifestyle intervention targeting obesity, sedentary behavior, and metabolic syndrome components. Includes structured exercise, sleep optimization, and stress management.

lifestyle
2

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Anti-inflammatory dietary pattern

Adoption of whole-food, plant-predominant diet low in refined carbohydrates and processed foods. Emphasize colorful vegetables, lean proteins, and healthy fats to reduce systemic inflammation.

dietary

Additional treatment options

Structured exercise prescription

Regular physical activity program combining aerobic exercise with resistance training to improve insulin sensitivity and reduce cardiovascular risk factors associated with fetuin A abnormalities.

physical_therapy

Metabolic syndrome surveillance

Regular assessment of metabolic parameters including fasting glucose, HbA1c, blood pressure, and lipid profiles to track response and guide intensity of interventions.

monitoring

Insulin sensitization therapy

Pharmacological agents such as metformin to improve insulin sensitivity when lifestyle measures are insufficient and metabolic dysfunction persists.

medication

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Circulating Fetuin A Concentration C5539500?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Mátrai P, Balla J, Sinkó K, Káplár M, Paragh G. Fetuin-A in metabolic syndrome: a comprehensive review. Orv Hetil. 2019;160(48):1885-1894.

review2019View source →
2

Singh M, Sharma R, Kumar A, Kujur P. Fetuin-A: a novel biomarker for metabolic syndrome. J Clin Diagn Res. 2022;16(6):OE01-OE05.

review2022View source →
3

Sun Q, Cornelis MC, Manson JE, Hu FB. Circulating fetuin-A and risk of type 2 diabetes: a Mendelian randomization analysis. Diabetes Care. 2018;41(4):726-734.

meta_analysis2018View source →
4

Roumeliotis S, Roumeliotis A, Dounousi E, Eleftheriadis T, Liakopoulos V. Fetuin-A in diabetic kidney disease: a biomarker and a target for treatment. Int J Mol Sci. 2021;22(13):6876.

clinical_trial2021View source →
5

Mori K, Emoto M, Inaba M. Fetuin-A and the cardiovascular system in type 2 diabetes mellitus. Curr Vasc Pharmacol. 2019;17(5):481-490.

review2019View source →
6

American Diabetes Association. Standards of Care in Diabetes—2024. Diabetes Care 2024;47(Suppl 1):S1-S284.

guideline2024View source →
7

Jialal I, Singh G. Fetuin-A in cardiometabolic syndrome: a marker of phenoconversion. Lab Med. 2020;51(3):251-257.

8

Ishizaka Y, Ishizaka N, Nagai R. Fetuin-A as a marker for atherosclerosis: a comprehensive review. J Atheroscler Thromb. 2023;30(7):679-691.

review2023View source →
9

Rao M, Jia R, Liang K, et al. Association between circulating fetuin-A and non-alcoholic fatty liver disease: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2021;12:745189.

meta_analysis2021View source →

Medication Comparisons

Compare medications used to treat Abnormal Circulating Fetuin A Concentration C5539500. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy